Patents Assigned to BioMAS Ltd.
-
Publication number: 20230285788Abstract: The disclosure relates to firefighting measures, and in particular, to firefighting compositions for preventing, retarding and extinguishing fire in a combustion zone that comprises a combination of at least one cooling component, at least one fire-isolation component comprising, at least one oxidizer diluting component, and at least one flame retarding component.Type: ApplicationFiled: August 8, 2021Publication date: September 14, 2023Applicant: BIOMA LTDInventors: Andrey Valerievich AGAFONOV, Boris MELNIK
-
Patent number: 9700536Abstract: Novel formulations of tellurium-containing compounds, which are suitable for topical application, are disclosed. The formulations are characterized by high chemical and physical stability and are easy to handle and use.Type: GrantFiled: November 10, 2015Date of Patent: July 11, 2017Assignee: BIOMAS LTD.Inventors: Michael Albeck, Benjamin Sredni, Doron Friedman
-
Patent number: 9216197Abstract: Novel formulations of tellurium-containing compounds, which are suitable for topical application, are disclosed. The formulations are characterized by high chemical and physical stability and are easy to handle and use.Type: GrantFiled: September 10, 2007Date of Patent: December 22, 2015Assignee: BIOMAS LTD.Inventors: Michael Albeck, Benjamin Sredni, Doron Firedman
-
Patent number: 9011933Abstract: A novel method for treating skin and mucosal membrane ailments caused by human papilloma viruses, which utilizes tellurium-containing compounds, is disclosed. Also disclosed are pharmaceutical compositions containing tellurium-containing compounds for treating such ailments.Type: GrantFiled: January 23, 2005Date of Patent: April 21, 2015Assignee: Biomas Ltd.Inventors: Benjamin Sredni, Michael Albeck
-
Publication number: 20150023914Abstract: Methods for treating skin conditions such as basal cell carcinoma and/or actinic keratosis are provided, which are effected by administering a pharmaceutically effective amount of a tellurium-containing compound. A pharmaceutical composition for treatment of skin conditions such as basal cell carcinoma and/or actinic keratosis is also provided.Type: ApplicationFiled: April 21, 2014Publication date: January 22, 2015Applicant: BioMAS Ltd.Inventors: Benjamin SREDNI, Michael ALBECK
-
Publication number: 20140194496Abstract: Methods and compositions for inhibiting integrin and treating integrin-related conditions, utilizing tellurium-containing compounds, are disclosed. The tellurium-containing compounds comprise at least one tellurium dioxo moiety and may have any one of Formulae I to IV as defined in the specification. Further disclosed are methods and compositions for treating a neoplastic condition characterized by a resistance to an anti-neoplastic agent and by a high level of expression of an integrin by neoplastic cells.Type: ApplicationFiled: March 13, 2014Publication date: July 10, 2014Applicant: BIOMAS LTD.Inventors: Benjamin SREDNI, Michael ALBECK
-
Patent number: 8703753Abstract: Methods for treating skin conditions such as basal cell carcinoma and/or actinic keratosis are provided, which are effected by administering a pharmaceutically effective amount of a tellurium-containing compound. A pharmaceutical composition for treatment of skin conditions such as basal cell carcinoma an/or actinic keratosis is also provided.Type: GrantFiled: September 14, 2006Date of Patent: April 22, 2014Assignee: Biomas Ltd.Inventors: Benjamin Sredni, Michael Albeck
-
Patent number: 8623908Abstract: Use of tellurium-containing compounds for treating conditions in which inhibition of caspase-1/interleuFkin-1? enzyme (ICE) is beneficial is disclosed.Type: GrantFiled: March 22, 2010Date of Patent: January 7, 2014Assignee: Biomas Ltd.Inventors: Michael Albeck, Benjamin Sredni
-
Publication number: 20120157519Abstract: Tellurium-containing compounds identified for use in a method of treating, or prophylaxis against, a viral infection caused by an influenza virus, uses thereof and pharmaceutical kits and pharmaceutical corn positions comprising the same, are disclosed. The tellurium-containing compounds disclosed herein are suitable for co-administration with an antiviral agent.Type: ApplicationFiled: June 16, 2010Publication date: June 21, 2012Applicant: Biomas Ltd.Inventors: Benjamin Sredni, Michael Albeck
-
Publication number: 20120035260Abstract: Use of tellurium-containing compounds in a method of conception and/or for maintaining and/or augmenting fertility in female following chemotherapy and/or radiotherapy is disclosed. The tellurium-containing compound is utilized in combination with a chemotherapeutic agent and/or radiation, such that the female treated by the chemotherapeutic agent and/or radiation and by the tellurium-containing compound is instructed to refrain from conceptive sex for a pre-determined time period, following the chemotherapy and/or radiotherapy, during which conception is undesired. The tellurium-containing compound is utilized in combination with a chemotherapeutic agent and/or radiation, such that the female treated by the chemotherapeutic agent and/or radiation and by the tellurium-containing compound is instructed to refrain from sex and/or from reproduction for a pre-determined time period, and is then allowed to practice reproduction.Type: ApplicationFiled: January 7, 2010Publication date: February 9, 2012Applicant: BIOMAS LTD.Inventors: Benjamin Sredni, Dror Meirow, Michael Albeck, Benjamin Ron
-
Publication number: 20110275709Abstract: Use of tellurium-containing compounds for maintaining and/or augmenting fertility in a male subject following chemotherapy and/or radiotherapy is disclosed. The tellurium-containing compound is utilized in combination with a chemotherapeutic agent and/or radiation, such that the male subject treated by the chemotherapeutic agent and/or radiation and by the tellurium-containing compound is instructed to refrain from conceptive sex for a pre-determined time period, following the chemotherapy and/or radiotherapy, during which conception is undesired.Type: ApplicationFiled: January 7, 2010Publication date: November 10, 2011Applicant: BIOMAS LTD.Inventors: Benjamin Sredni, Michael Albeck, Benjamin Ron
-
Patent number: 8048915Abstract: The invention relates to an aqueous solution containing at least one species selected from the group consisting of a 1:1 molar complex of TeO2 with a moiety of formula (A) and ammonium salts thereof: HO—X—OH ??(A) where X is an optionally substituted divalent saturated hydrocarbon group containing 2-8 carbon atoms in the chain connecting the two OH groups; and its use for stimulating cells to produce cytokines and for treating mammalian diseases and conditions responsive to increased production of cytokines. The complex may be used also for treating mammalian cancer which is not responsive to increased production of cytokines.Type: GrantFiled: December 7, 2009Date of Patent: November 1, 2011Assignee: BioMas Ltd.Inventors: Michael Albeck, Benjamin Sredni
-
Publication number: 20100233294Abstract: Use of tellurium-containing compounds for treating conditions in which inhibition of caspase-1/interleuFkin-1? enzyme (ICE) is beneficial is disclosed.Type: ApplicationFiled: March 22, 2010Publication date: September 16, 2010Applicant: BioMAS Ltd.Inventors: Michael ALBECK, Benjamin Sredni
-
Publication number: 20100150869Abstract: Methods for treating skin conditions such as basal cell carcinoma and/or actinic keratosis are provided, which are effected by administering a pharmaceutically effective amount of a tellurium-containing compound. A pharmaceutical composition for treatment of skin conditions such as basal cell carcinoma an/or actinic keratosis is also provided.Type: ApplicationFiled: September 14, 2006Publication date: June 17, 2010Applicant: BioMAS Ltd.Inventors: Benjamin Sredni, Michael Albeck
-
Patent number: 7732433Abstract: The invention relates to an aqueous solution containing at least one species selected from the group consisting of a 1:1 molar complex of TeO2 with a moiety of formula (A) and ammonium salts thereof: HO—X—OH (A); where X is an optionally substituted divalent saturated hydrocarbon group containing 2-8 carbon atoms in the chain connecting the two OH groups; and its use for stimulating cells to produce cytokines and for treating mammalian diseases and conditions responsive to increased production of cytokines. The complex may be used also for treating mammalian cancer which is not responsive to increased production of cytokines.Type: GrantFiled: September 11, 2007Date of Patent: June 8, 2010Assignee: BioMAS Ltd.Inventors: Michael Albeck, Benjamin Sredni
-
Patent number: 7709524Abstract: Use of tellurium-containing compounds for treating conditions in which inhibition of caspase-1/interleukin-1? enzyme (ICE) is beneficial is disclosed.Type: GrantFiled: September 15, 2005Date of Patent: May 4, 2010Assignee: BioMAS Ltd.Inventors: Michael Albeck, Benjamin Sredni
-
Publication number: 20100087521Abstract: The invention relates to an aqueous solution containing at least one species selected from the group consisting of a 1:1 molar complex of TeO2 with a moiety of formula (A) and ammonium salts thereof: HO—X—OH ??(A) where X is an optionally substituted divalent saturated hydrocarbon group containing 2-8 carbon atoms in the chain connecting the two OH groups; and its use for stimulating cells to produce cytokines and for treating mammalian diseases and conditions responsive to increased production of cytokines The complex may be used also for treating mammalian cancer which is not responsive to increased production of cytokinesType: ApplicationFiled: December 7, 2009Publication date: April 8, 2010Applicant: BioMAS Ltd.Inventors: Michael ALBECK, Benjamin Sredni
-
Publication number: 20100081623Abstract: Novel tellurium-containing compounds and uses thereof as immunomodulators are disclosed.Type: ApplicationFiled: December 2, 2009Publication date: April 1, 2010Applicant: BioMAS Ltd.Inventors: Michael ALBECK, Benjamin Sredni
-
Publication number: 20100062081Abstract: A novel neuroprotective agent is disclosed for the treatment and prevention of neurodegenerative disorders which is based on the administration of an effective amount of a tellurium compound which has a specific ability to induce the differentiation and interfere with apoptotic cell death pathways of neuronal PC-12 cells.Type: ApplicationFiled: November 12, 2009Publication date: March 11, 2010Applicant: BioMAS Ltd.Inventors: Benjamin Sredni, Michael Albeck
-
Publication number: 20100055055Abstract: Novel formulations of tellurium-containing compounds, which are suitable for topical application, are disclosed. The formulations are characterized by high chemical and physical stability and are easy to handle and use.Type: ApplicationFiled: September 10, 2007Publication date: March 4, 2010Applicant: BioMAS Ltd.Inventors: Michael Albeck, Benjamin Sredni, Doron Firedman